Article
Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays
5 Aug 2022
Abstract excerpt
In the United States (U.S.), a hepatitis E virus (HEV) seroprevalence between 6 and 21% has been described, with a decreasing trend. We aimed to investigate HEV infection in the U.S. population from 2009 to 2016, and examine the differences in seroprevalence using different assays. We used data from the National Health and Nutrition Examination Survey (NHANES-CDC) to estimate HEV seroprevalence and analyze...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
